Stock Price Quote

CADILA HEALTHCARE LTD.

NSE : CADILAHCBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE390.702.8 (+0.72 %)
PREV CLOSE ( ) 387.90
OPEN PRICE ( ) 389.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 145370
TODAY'S LOW / HIGH ( )387.85 395.40
52 WK LOW / HIGH ( )206.45 411.6
NSE390.902.05 (+0.53 %)
PREV CLOSE( ) 388.85
OPEN PRICE ( ) 390.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 390.90 (877)
VOLUME 4604458
TODAY'S LOW / HIGH( ) 387.55 395.30
52 WK LOW / HIGH ( )202 411.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-05 1995
Management Info
Pankaj R Patel - Chairman Sharvil P Patel - Managing Director
Registered Office

Address Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-382481

Phone 079- 26868100 /26868101 /26868102 /26868103 / 04 / 05 / 06 / 07 / 08 / 09 / 10 / 11 / 12 / 13 / 14 / 15 / 16 / 17 / 18 / 19 / 20

Email investor.grievance@zyduscadila.com

Website www.zyduscadila.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX

NEWS

06Aug Cadila Healthcare reports 50% rise in
Cadila Healthcare has reported results for first quarter ended June 30,..
03Aug Zydus Cadila gets USFDA’s tentative no
Zydus Cadila has received tentative approval from the US Food and Drug A..
03Aug Cadila Healthcare trades higher on the
Cadila Healthcare is currently trading at Rs. 392.40, up by 3.95 points..
27Jul Cadila Healthcare informs about board
Cadila Healthcare has informed that the meeting of the Board of Director..
23Jul Zydus Cadila gets USFDA’s nod to initi
Zydus Cadila has received approval from US Food and Drug Administration..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit398214129
Gross Profit 4784 15577
Operating Profit 609222725
Net Sales 1795963474

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4667.60 (6.04%)
M.Cap ( in Cr)7747.93
Valiant Organics (BSE)
peergroup  2610.70 (9.39%)
M.Cap ( in Cr)3171.80
Aarti Drugs (BSE)
peergroup  2353.60 (5.68%)
M.Cap ( in Cr)5483.89
Alkem Laboratories (BSE)
peergroup  2980.30 (4.06%)
M.Cap ( in Cr)35633.96
Abbott India (BSE)
peergroup  16188.60 (0.29%)
M.Cap ( in Cr)34399.65

Shareholding Pattern

PROMOTERS 74.88%
NON-INSTITUTION 7.78%
MUTUAL FUNDS/UTI 7.47%
FI/BANKS/INSURANCE 5.04%
GOVERNMENT 0.19%
FII 0%

About Cadila Healthcare Ltd.

Cadila Healthcare Ltd. was incorporated in the year 1995. Its today's share price is 387.9. Its current market capitalisation stands at Rs 39997.62 Cr. In the latest quarter, company has reported Gross Sales of Rs. 68497 Cr and Total Income of Rs.77023 Cr. The company's management includes Apurva S Diwanji, Dharmishta N Raval, Nitin R Desai, Bhadresh K Shah, Mukesh M Patel, Ganesh N Nayak, Sharvil P Patel, Pankaj R Patel.

It is listed on the BSE with a BSE Code of 532321 , NSE with an NSE Symbol of CADILAHC and ISIN of INE010B01027. It's Registered office is at Zydus Corporate Park, Scheme No.63,Survey No. 536, Khoraj(gandhinagar), Nr. Vaishnodevi Circle,Sarkhej - Gandhinagar HighwayAhmedabad-382481, Gujarat. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Mukesh M Shah & Co, RR Patel & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)